Recent reports suggest that activated ceramide induces caspase-1 activation, IL-1β production in an Nlrp3 inflammasome dependent mechanism in obesity or acute lung injury [6, 7]. Here, CASP1 is linked to obesity due to melanocortin 4 receptor deficiency.